Patents by Inventor Nerea TORRES ANTÚNEZ

Nerea TORRES ANTÚNEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES AGAINST BIOLOGICAL DRUGS
    Publication number: 20210011037
    Abstract: A lateral flow immunoassay for the detection of anti-drug antibodies against a biological drug includes a membrane having a capture area, a sample application area, a flow path from the sample application area to the capture area, and a conjugate area located in the flow path. The conjugate area has said biological drug detectably labeled and the capture area has said biological drug immobilized thereto.
    Type: Application
    Filed: September 21, 2020
    Publication date: January 14, 2021
    Inventors: ANTONIO MARTINEZ MARTINEZ, DANIEL NAGORE CASAS, ALBERTO MONASTERIO ASTEINZA, NEREA TORRES ANTÚNEZ
  • Lateral flow immunoassays for the detection of antibodies against biological drugs
    Patent number: 10830779
    Abstract: A lateral flow immunoassay for the detection of anti-drug antibodies against a biological drug includes a membrane having a capture area, a sample application area, a flow path from the sample application area to the capture area, and a conjugate area located in the flow path. The conjugate area has said biological drug detectably labeled and the capture area has said biological drug immobilized thereto.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: November 10, 2020
    Assignee: PROGENIKA BIOPHARMA, S.A.
    Inventors: Antonio Martinez Martinez, Daniel Nagore Casas, Alberto Monasterio Asteinza, Nerea Torres Antúnez
  • LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES AGAINST BIOLOGICAL DRUGS
    Publication number: 20170234896
    Abstract: A lateral flow immunoassay for the detection of anti-drug antibodies against a biological drug includes a membrane having a capture area, a sample application area, a flow path from the sample application area to the capture area, and a conjugate area located in the flow path. The conjugate area has said biological drug detectably labeled and the capture area has said biological drug immobilized thereto.
    Type: Application
    Filed: July 27, 2015
    Publication date: August 17, 2017
    Inventors: Antonio MARTINEZ MARTINEZ, Daneil NAGORE CASAS, Alberto MONASTERIO ASTEINZA, Nerea TORRES ANTÚNEZ